# NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Dec 31, 2019

- Company: [NEUROONE MEDICAL TECHNOLOGIES Corp](/companies/nmtc.md) (CIK 1500198)
- Form: 10-Q
- Filed: 2020-02-14
- Accepted by EDGAR: Feb 14, 2020, 20:52 ET
- Period: 2019-12-31
- Accession: 0001213900-20-003930
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1500198/000121390020003930/f10q1219_neuroonemedical.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1500198/000121390020003930/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2019-10-01 to 2019-12-31 | $501.8k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2019-10-01 to 2019-12-31 | −$1.8m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2019-10-01 to 2019-12-31 | −$4.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-10-01 to 2019-12-31 | −$0.34 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months, 2019-10-01 to 2019-12-31 | −$1.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2019-10-01 to 2019-12-31 | $10.3k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2019-12-31 | $2.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-12-31 | $2.1m | us-gaap:AssetsCurrent |
| Total assets | at 2019-12-31 | $2.7m | us-gaap:Assets |
| Current liabilities | at 2019-12-31 | $7.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-12-31 | $7.3m | us-gaap:Liabilities |
| Short-term borrowings | at 2019-12-31 | $5.2m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2019-12-31 | −$4.6m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1500198/000121390020003930/f10q1219_neuroonemedical.htm

Filed Feb 14, 2020.
Source: SEC EDGAR, the filing index for accession 0001213900-20-003930. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
